Xofigo and Lasix drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Xofigo (radium ra-223 dichloride) and Lasix (furosemide). Common drug interactions include fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Xofigo and Lasix. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Xofigo?

Xofigo has active ingredients of radium ra-223 dichloride. eHealthMe is studying from 4,948 Xofigo users. Check the latest studies of Xofigo.

What is Lasix?

Lasix has active ingredients of furosemide. It is often used in swelling. eHealthMe is studying from 210,439 Lasix users. Check the latest studies of Lasix.



On Aug, 11, 2026

31 people who take Xofigo and Lasix together, and have interactions are studied.

Xofigo and Lasix drug interactions.

What are the common drug interactions of Xofigo and Lasix, by gender? *:

female:

n/a

male:

  1. Fatigue (feeling of tiredness)
  2. Anaemia (lack of blood)
  3. Platelet count decreased
  4. Hypotension (abnormally low blood pressure)
  5. Asthenia (weakness)
  6. Cardiac failure chronic
  7. Pain in extremity
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Metastases to lymph nodes (cancer spreads to lymph node)
  10. Osteonecrosis of jaw (death of bone of jaw)

What are the common drug interactions of Xofigo and Lasix, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Fatigue (feeling of tiredness)
  2. Anaemia (lack of blood)
  3. Hypotension (abnormally low blood pressure)
  4. Cardiac failure chronic
  5. Nausea (feeling of having an urge to vomit)
  6. Pain in extremity
  7. Metastases to lymph nodes (cancer spreads to lymph node)
  8. Osteonecrosis of jaw (death of bone of jaw)
  9. Prostate cancer stage iv
  10. Asthenia (weakness)

What are the existing conditions these people have? *

  1. Prostate Cancer: 14 people, 45.16%
  2. Metastases To Bone (cancer spreads to bone): 13 people, 41.94%
  3. Prostate Cancer Stage Iv: 5 people, 16.13%
  4. Prostate Cancer Metastatic: 5 people, 16.13%
  5. Pain: 3 people, 9.68%
  6. High Blood Pressure: 2 people, 6.45%
  7. Cardiac Failure Chronic: 2 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Xofigo and Lasix?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Xofigo and Lasix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Xofigo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lasix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Xofigo and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lasix and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on radium ra-223 dichloride and furosemide (the active ingredients of Xofigo and Lasix, respectively), and Xofigo and Lasix (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: